Capital Access Group

Capital Access Group advises companies on effective engagement with investors. Our experienced team offers market-leading access with hard-to-reach investors, including smaller institutions, pension funds and private client fund managers. These under-serviced investors are located not only in London but across the regions of the UK and Europe. We have an unrivalled knowledge of this extensive audience, to whom our published research is distributed, as well as to larger institutions. We offer this service as part of an integrated investor communications strategy to promote a company’s investment story.

Our clients, ranging from AIM to FTSE 100 companies, benefit from our professional, long-term relationships with investors. Not only do we identify and target investors, we contact them directly and relay their views back to clients with analysis, interpretation and advice. This ensures that our clients are in control of their investor engagement. The objective is to improve the reach and engagement with investors, which in turn strengthens the share price.

Colin Smith
  • Colin Smith

Seplat Energy - MPNU Completion: Management call feedback

Seplat completed its transformational acquisition of MPNU last week more than doubling production to 120kboed and nearly doubling 2P reserves to 0.9bnboe. The payment on completion of US$672m was funded from existing and new facilities without any new equity. Management highlighted the multiple improved operational and financial metrics resulting from completion and addressed concerns in the market, most notably the reinvestment potential into what has been a well run but cash starved business, ...

Sarah Godfrey
  • Sarah Godfrey

Supermarket Income REIT | Initiation of Coverage: Bagging a bargain

Supermarket Income REIT (SUPR) is a specialist property fund that seeks to achieve attractive levels of defensive, long-dated income from a portfolio of grocery stores, mainly in the UK although a recent move into France has provided diversification. While supermarket operators' margins have been squeezed in the recent period of higher inflation, market growth remains solid, and consumers are beginning to trade back up to more premium products as they see their wages rise and price increases mod...

Colin Smith
  • Colin Smith

Duke Capital - 1H25 Results - On Track and Well Funded

Duke Capital has announced interim results for 1H25 which are on track to meet our FY25 forecasts with recurring cash revenue of £12.7m, up 4% YoY. The group deployed over £15m in new capital to its capital partners during the half. Post period end, Duke successfully completed an oversubscribed £23.5m equity raise, materially strengthening its balance sheet and intends future capital funding to be generated by way of a third-party capital model. Duke is trading at a c25% discount to book despite...

Colin Smith
  • Colin Smith

Seplat Energy - Transformational MPNU deal completion imminent

Seplat has published the prospectus for its reverse takeover of MPNU with the deal expected to close on Thursday, 12th December. This has been a long time coming and is transformational for the company, more than doubling production to 120kboed and nearly doubling 2P reserves to 0.9bnboe. The final payment on completion is US$672m for a total payment of US$800m including the deposit already paid. Funding is from Seplat's existing cash and revolving credit facility, together with a new US$300m th...

Colin Smith
  • Colin Smith

TheraCryf |1HFY25 results – Cash guidance confirmed

The first half of FY25 has been a busy one for TheraCryf. The company closed the Chronos acquisition, trebling its pipeline of development assets, and it completed a £0.9m equity raise. The Erasmus University study on SFX-01, the company's lead clinical asset, is making good progress while the granting of a patent covering the company's Orexin-1 molecule by the European Patent Office has just been announced. Despite its advantages, TheraCryf trades on a fraction of the rating of most peers with...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch